 NEW YORK and LONDON, Feb. 03, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences plc NASDAQ:TLSALSE:TILS Tiziana or the Company, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced an interview with Dr. Kunwar Shailubhai, CEO and CSO, is now available. 